Abstract

Introduction The aim of this study is to document time intervals in cervical cancer care pathways, from symptom onset to disease detection and start of treatment, and evaluate how clinical, sociodemographic, and treatment factors influence delays throughout a patient's clinical pathway. Methods A retrospective study was conducted at the FEZ Oncology Hospital of the Hassan II University Hospital Center in Morocco. Results 190 medical records of cervical cancer patients were collected. The dominant age group was 35–44, the median patient delay (PD) was 6 days, the median healthcare provider's delay (HCP) was 21 days, the median referral delay (RD) was 17 days, the median diagnostic delay (DD) was 9.5 days, the median total diagnostic delay (TDD) was 16 days, the median treatment delay (TD) was 67 days, and the median health system interval (HSI) was 92 days. Multivariate analysis revealed that age was associated with the patient delay, the healthcare provider's delay, the diagnosis delay, and the health system interval. The diagnosis year (the year in which the patient was diagnosed (either before 2012 or during 2012 as well as the other study years (from 2013 to 2017))), all investigations done prior to admission to the oncology hospital, and the age of first sexual activity were significantly associated with healthcare provider's delay. Conclusion The integration of a model and standard care pathway into the Moroccan health system is essential in order to unify cervical cancer care in the country.

Highlights

  • Cervical cancer is the fourth most common cancer in women with approximately 570,000 new cases in 2018, representing 6.6% of all female cancers

  • The concept of delayed diagnosis has become as an important issue. It is categorized into four components including patient delay, healthcare provider’s delay, referral delay, and system delay [6,7]. erefore, this study aimed to document time intervals in cervical cancer care pathways, from symptoms onset to disease detection and start of treatment, between 2013 and 2017, and assess how clinical, sociodemographic, and treatment factors influence delays

  • Results revealed that the median patient delay was 6 days, median healthcare provider’s delay was 21 days, median referral delay was 17 days, median diagnostic time was 9.5 days, median total diagnosis delay was 16 days, median treatment delay was 67 days, and median health system interval was 92 days. e total diagnosis delay of more than 90 days was defined as “long diagnostic delay” and 90 days or less as “short diagnostic delay” [9]. e current study showed that the median total

Read more

Summary

The Care Pathway Delays of Cervical Cancer Patient in Morocco

Hind Mimouni ,1 Khalid Hassouni, Boujemaa El Marnissi, Bouchra Haddou Rahou, Leila Alaoui, Rachid Ismaili, Abderraouf Hilali, Leila Loukili, Rachid Bekkali, and Ahmed Nejmeddine. E dominant age group was 35–44, the median patient delay (PD) was 6 days, the median healthcare provider’s delay (HCP) was 21 days, the median referral delay (RD) was 17 days, the median diagnostic delay (DD) was 9.5 days, the median total diagnostic delay (TDD) was 16 days, the median treatment delay (TD) was 67 days, and the median health system interval (HSI) was 92 days. Multivariate analysis revealed that age was associated with the patient delay, the healthcare provider’s delay, the diagnosis delay, and the health system interval. E diagnosis year (the year in which the patient was diagnosed (either before 2012 or during 2012 as well as the other study years (from 2013 to 2017))), all investigations done prior to admission to the oncology hospital, and the age of first sexual activity were significantly associated with healthcare provider’s delay. Conclusion. e integration of a model and standard care pathway into the Moroccan health system is essential in order to unify cervical cancer care in the country

Introduction
July August September October
Results
Menopause Yes No Not available
Multistakeholder consultation meeting
Age of first sexual activity Hospital referrer
Investigation before the oncology center
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.